CRISTINA WOODS: Open Payments
NPI 1215671003 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $254 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| GENZYME CORPORATION | 1 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
Products named: REZDIFFRA, Kerendia, Epclusa, FABRAZYME, TZIELD.
Industry payments across LA — which companies pay providers there.
